Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Acquisitions (2019 - 2025)

Marimed (MRMD) has disclosed Acquisitions for 5 consecutive years, with -$231000.0 as the latest value for Q1 2025.

  • Quarterly Acquisitions changed N/A to -$231000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$231000.0 through Dec 2025, down 105.44% year-over-year, with the annual reading at -$231000.0 for FY2025, 105.44% down from the prior year.
  • Acquisitions for Q1 2025 was -$231000.0 at Marimed, down from $4.2 million in the prior quarter.
  • The five-year high for Acquisitions was $4.2 million in Q2 2024, with the low at -$231000.0 in Q1 2025.
  • Average Acquisitions over 4 years is $1.5 million, with a median of $1.0 million recorded in 2022.
  • The sharpest move saw Acquisitions tumbled 100.41% in 2023, then soared 53225.0% in 2024.
  • Over 4 years, Acquisitions stood at $101000.0 in 2022, then tumbled by 107.92% to -$8000.0 in 2023, then skyrocketed by 53225.0% to $4.2 million in 2024, then tumbled by 105.44% to -$231000.0 in 2025.
  • According to Business Quant data, Acquisitions over the past three periods came in at -$231000.0, $4.2 million, and -$8000.0 for Q1 2025, Q2 2024, and Q2 2023 respectively.